Author

N. Perdigones

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:whole-exome sequencing· 2 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Approach:statistical model· 1 Research Focus:variant calling· 1

Frequent Co-Authors

K. Sivaprakasam· 2 shared M. Murtaza· 2 shared S. Facista· 2 shared S. Wong· 2 shared T. Contente-Cuomo· 2 shared V. Zismann· 2 shared W. P. D. Hendricks· 2 shared A. Nazareno· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

K. Sivaprakasam

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genomic landscapes of canine splenic angiosarcoma (hemangiosarcoma) contain extensive heterogeneity within and between patients

S. Wong, E. Ehrhart, S. Stewart, V. Zismann, J. Cawley, R. Halperin, N. Briones, K. Richter, K. Sivaprakasam, N. Perdigones, T. Contente-Cuomo, S. Facista, J. M. Trent, M. Murtaza, C. Khanna, W. P. D. Hendricks

This study examines genomic heterogeneity in canine splenic hemangiosarcoma, identifying driver mutations and intratumoral diversity across multiple regions.

bioRxiv · Nov 15, 2020Cancer Biology

Identification of frequent activating HER2 mutations in primary canine pulmonary adenocarcinoma

G. Lorch, K. Sivaprakasam, V. Zismann, N. Perdigones, T. Contente-Cuomo, A. Nazareno, S. Facista, S. Wong, K. Drenner, W. S. Liang, J. M. Amann, S. L. Sinicropi-Yao, M. J. Koenig, K. La Perle, T. G. Whitsett, , W. P. D. Hendricks

This study identifies HER2 mutations in canine pulmonary adenocarcinomas, finding V659E mutations in 38% of cases and their association with drug sensitivity.

bioRxiv · Feb 25, 2019 · PreprintCancer Biology